Multiplex-Edited CAR-T in GBM: Building a Blueprint to Overcome TME Barriers

• Lessons from prior GBM CAR-T trials defining durability requirements and key TME barriers
• Rationale for multiplex editing and validation in patient-derived GBM models
• Why allogeneic CAR-T is well-suited for GBM compared to other modalities

Speakers:

Aaron Edwards

Co-Founder & Chief Executive Officer

KiraGen Bio